Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Diabetology & Metabolic Syndrome|February 7, 2023
A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary interventionJiawen Li, Pei Zhu, Yulong Li, et al.
International Journal of General Medicine|September 30, 2021
Length of Stay and Short-Term Outcomes in Patients with ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: Insights from the China Acute Myocardial Infarction RegistryJunxing Lv, Qinghao Zhao, Jingang Yang, et al.
The Canadian Journal of Cardiology|August 5, 2019
Validating the Performance of 5 Risk Scores for Major Adverse Cardiac Events in Patients Who Achieved Complete Revascularization After Percutaneous Coronary InterventionDong Zhang, Ruohua Yan, Guofeng Gao, et al.
Journal of Interventional Cardiology|November 28, 2019
Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center DataRu Liu, Zhan Gao, Huanhuan Wang, et al.
Cardiovascular Therapeutics|June 5, 2018
Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary interventionPei Zhu, Xiaofang Tang, Jingjing Xu, et al.
Circulation. Cardiovascular Interventions|May 18, 2022
New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational StudyHao-Yu Wang, Ke-Fei Dou, Changdong Guan, et al.
Circulation|March 29, 2020
CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 EpidemicYaling Han, Hesong Zeng, Hong Jiang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 2, 2017
Impact of residual SYNTAX score on clinical outcomes after incomplete revascularisation percutaneous coronary intervention: a large single-centre studyYing Song, Zhan Gao, Xiaofang Tang, et al.
BMC Cardiovascular Disorders|February 23, 2023
Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction RegistryChao Wu, Ling Li, Shuqing Wang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 13, 2017
Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center studyYing Song, Zhan Gao, Xiaofang Tang, et al.
Pageof 32